ArticleFrontiers in immunology2026

Outcomes of low-dose immune tolerance induction with single-dose rituximab in severe hemophilia A: a single-center retrospective experience.

Shaoyu Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.